Patent · US Active

Kits and methods for induction of cardioversion in subjects with atrial arrhythmias

US12059414B2 · kind B2 · utility

0Cited by

11References

12Claims

0Family size

Assignee

InCarda Therapeutics, Inc. · US

Inventors

Luiz Belardinelli · Palo Alto, US
Carlos Schuler · Cupertino, US
Miguel Guzman · Cupertino, US

Key dates

Filing date	Mar 30, 2022
Grant date	Aug 13, 2024
Priority date	—
Expiry date	Mar 30, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using potassium channel inhibitors and class I antiarrhythmic agents. Also disclosed herein are methods and kits for treating a heart condition via an intravenously, orally, or inhalationally administered fixed-dose combination of a sodium channel blocker and a class I antiarrhythmic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.